Menu

Experience

Michael Tuscan

    • Iconic Therapeutics Series C Financing 


    • FibroGen Closes Largest Biotech IPO in 12 Years 


    • T2 Biosystems IPO 


    • Adamas Pharmaceuticals Initial Public Offering 


    • Versartis $145 Million IPO 


    • First US IPO of 2014 for GlycoMimetics 


Contact us

Back to top

© 2019 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.